We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Abbott Diagnostics

  Gold Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Amino Acids Predict Prognosis in Patients with Acute Dyspnea

By LabMedica International staff writers
Posted on 15 Nov 2021
Print article
Image: The AVANCE III, 500 MHz spectrometer has a room temperature QXI probe, triple axis gradients, temperature controller and automatic tuning (Photo courtesy of University of Idaho)
Image: The AVANCE III, 500 MHz spectrometer has a room temperature QXI probe, triple axis gradients, temperature controller and automatic tuning (Photo courtesy of University of Idaho)
The main symptom of dyspnea is labored breathing. It may last for a minute or two after strenuous activity or it could be a chronic problem. One of the most common symptoms in the emergency departments (ED) is dyspnea, presented in roughly 3 to 4 million annual ER visits in the USA.

Chronic cardiorespiratory diseases, which underlie susceptibility to episodes of acute dyspnea, and acute events leading to an exacerbation, pose severe challenges to the body and result in metabolic changes, often mediated by the release of stress hormones. The severity of the disease state in patients with acute dyspnea may also be related to increased levels of specific amino acids.

Clinical Scientists at Lund University (Malmo, Sweden) included in a study, 663 patients to identify amino acids that can predict risk of 90-day mortality in patients with acute dyspnea. Blood pressure, oxygen saturation and heart rate were measured using a fully automated oscillometric device (CARESCAPE Monitor B850 or B650, General Electric Healthcare, Chicago, IL, USA).

Plasma concentration of C-reactive protein (CRP), lactate and creatinine was measured using an ABL800 Flex machine (Radiometer, Crawley, UK) or Afinion AS100 Analyzer System (Abbott, Abbott Park, IL, USA). Frozen serum samples were analyzed using a proton nuclear magnetic resonance (NMR) platform, the AVANCE III, 500 MHz spectrometer (Bruker, Billerica, MA, USA), which included nine selected amino acids chosen for revision in the study.

The investigators reported that during the 90 days of follow-up, 80 patients died, 69 of whom had been admitted to a ward upon their arrival in the ED, and six patients died in the ED. An “Amino Acid Mortality Risk Score” (AMRS), summing absolute plasma levels of glycine, phenylalanine and valine, demonstrated that among the patients belonging to quartile 1 (Q1) of the AMRS, only four patients died, compared to 44 patients in quartile 4. Using Q1 of the AMRS as reference, each increment of 1 SD in the AMRS was associated with a hazard ratio (HR) of 2.15 for 90-day mortality, and the HR was > 9 times higher in Q4.

The authors concluded that glycine, phenylalanine and valine are associated with the risk of 90-day mortality in patients admitted to the ED with a primary symptom of acute dyspnea. A score using these amino acids may guide in risk assessment, supporting decision making processes to establish appropriate level of care and treatment intensity. The study was published on October 30, 2021 in the journal BMC Emergency Medicine.

Related Links:
Lund University
General Electric Healthcare
Radiometer
Abbott
Bruker


Gold Supplier
COVID-19 Real Time RT-PCR Kit
respiraScreen 1
New
Laboratory Automation System
UniVerse
New
SARS-CoV-2 Antigen Immunofluorescence System
Watmind SARS-CoV-2 Antigen Immunofluorescence System
New
Auto Multiparameter POC Analyzer
Triage MeterPro

Print article

Channels

Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Illustration

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.